UK Advisers Recommend Meningitis B Vaccine for Teenagers

The Joint Committee on Vaccination and Immunisation (JCVI) has recommended that teenagers be offered a vaccine against the deadly meningitis B (menB) strain on the National Health Service (NHS). This recommendation, which requires government approval, proposes that adolescents receive one or two doses of the menB vaccine around the age of 15. The JCVI also suggests implementing catch-up vaccination programs for individuals who might otherwise miss the opportunity to be immunized. The committee's advice aims to bolster protection against menB, a serious bacterial infection that can lead to severe disability or death, particularly in younger populations. The current NHS program offers the menB vaccine to infants, but this new recommendation extends the protective measure to adolescents, addressing potential gaps in immunity as children transition into their teenage years. The specific number of doses recommended for 15-year-olds will depend on whether they received a dose as an infant. This proactive approach by the JCVI seeks to further reduce the incidence and impact of menB disease in the UK population.